Addition of urinary management products furthers Medline’s position as urological devices market leader
Northfield, Ill., Dec.6, 2017 – To augment its growing focus on infection prevention solutions, Medline today announced a new distribution partnership with BioDerm, Inc. to provide customers with its line of alternative urinary management devices. Catheter-associated urinary tract infections (CAUTIs) are the fourth most common healthcare associated infection, and utilizing alternatives to Foley catheters is the best way to help avoid a CAUTI.
Starting Jan. 1, 2018, Medline will have exclusive distribution rights in the USA and Canada to Men’s Liberty Acute™, a male external catheter designed especially for the acute care market as a means of avoiding Foley catheter use by men within the appropriate patient diagnosis segment. Additionally, the company will distribute BioDerm’s portfolio of urinary management devices, such as the Men’s Liberty male external catheter for homecare and managed care, CathGrip® family of universal securement options, FreeDerm™ Adhesive Remover, BioPlus+™ Prep Wipe and KindKlamp™ Penile Clamp.
“BioDerm offers an alternative to indwelling Foley catheters to help minimize risk of infection to patients. Their products are a perfect fit in our ERASE CAUTI Comprehensive Care Solution to ensure customers have high quality tools for managing a patient’s bladder condition across all diagnoses,” says Sarah Dickinson, president of Medline’s Urology division.
Medline has collaborated with clinical leaders in hospitals nationwide to develop an effective and easy-to-adopt process that combines clinical thinking with product and educational resources to drive CAUTI prevention goals. Men’s Liberty Acute will work alongside the Medline bladder scanner to strengthen the Bladder Bundle of ERASE CAUTI and provide staff with a better alternative for managing a patient’s specific bladder condition.
“We couldn’t be happier with Medline, a leader in urology products and innovative solutions that reduce infection rates due to catheterization, as our partner. Thanks to Medline’s vast and knowledgeable sales force, the Men’s Liberty Acute™ product (as well as our other urology, securement and skin protection solutions) will now be more accessible to patients, thereby reducing the prevalence and associated risks of UTIs and improving their quality of life,” says Gaet Tyranski, president of BioDerm.
Medline is a global manufacturer and distributor serving the healthcare industry with medical supplies and clinical solutions that help customers achieve both clinical and financial success. Headquartered in Northfield, Ill., the company offers 350,000+ medical devices and support services through more than 1,400 direct sales representatives who are dedicated points of contact for customers across the continuum of care. For more information on Medline, go to www.medline.com or http://www.medline.com/social-media to connect with Medline on its social media channels.
BioDerm, Inc. is one of the nation’s leading manufacturers of proprietary hydrocolloid products for urinary management, securement, infection control and skin protection. Based in Largo, FL, a predominance of Bioderm’s products are manufactured locally. The company challenges accepted inferior standards of care by creating products that reduce infection rates, add comfort and reliability, and improve quality of life. BioDerm’s products are sold in over 20 countries worldwide. For more information on BioDerm’s line of products, visit www.Bioderminc.com or www.MensLiberty.com.